ResMed Inc
$
120.54
0 (0%)
| Volume: | 652,969 | Avg Vol (1m): | 581,280 |
| Market Cap $: | 17.28 Bil | Enterprise Value $: | 18.47 Bil |
| P/E (TTM): | 39.14 | P/B: | 8.61 |
| Earnings Power Value | 25.57 |
| Net Current Asset Value | -6.75 |
| Tangible Book | -3.01 |
| Projected FCF | 45.3 |
| Median P/S Value | 79.65 |
| Graham Number | 0 |
| Peter Lynch Value | 23.38 |
| DCF (FCF Based) | 72.79 |
| DCF (Earnings Based) | 53.48 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 6/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | 0.11 |
Cash-To-Debt ranked
lower than
60.98%
of
205
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
RMD:
0.11
Ranked among companies with meaningful Cash-To-Debt only.
|
Cash-To-Debt range over the past 10 years
Min: 0.11, Med: 2.33, Max: 10000
Current: 0.11
|
| Equity-to-Asset | 0.49 |
Equity-to-Asset ranked
lower than
55.61%
of
196
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
RMD:
0.49
Ranked among companies with meaningful Equity-to-Asset only.
|
Equity-to-Asset range over the past 10 years
Min: 0.34, Med: 0.74, Max: 0.86
Current: 0.49
|
| Debt-to-Equity | 0.66 |
Debt-to-Equity ranked
lower than
65.49%
of
142
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 3.57, Med: 0.37, Min: 0.01
RMD:
0.66
Ranked among companies with meaningful Debt-to-Equity only.
|
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.16, Max: 1.54
Current: 0.66
|
| Debt-to-EBITDA | 1.82 |
Debt-to-EBITDA ranked
higher than
56.88%
of
109
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 66.68, Med: 1.88, Min: 0.02
RMD:
1.82
Ranked among companies with meaningful Debt-to-EBITDA only.
|
Debt-to-EBITDA range over the past 10 years
Min: 0.27, Med: 0.59, Max: 2.18
Current: 1.82
|
| Interest Coverage | 21.27 |
Interest Coverage ranked
lower than
57.66%
of
137
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 21607070, Med: 63.92, Min: 0.47
RMD:
21.27
Ranked among companies with meaningful Interest Coverage only.
|
Interest Coverage range over the past 10 years
Min: 16.18, Med: 61.51, Max: 151.83
Current: 21.27
|
| Piotroski F-Score | 6 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 7.10 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.31 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC 19.19%
WACC 4.03%
| ||
Profitability & Growth : 8/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 24.50 |
Operating Margin ranked
higher than
87.56%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
RMD:
24.5
Ranked among companies with meaningful Operating Margin only.
|
Operating Margin range over the past 10 years
Min: 20.67, Med: 22.86, Max: 26.46
Current: 24.5
|
| Net Margin % | 17.65 |
Net Margin ranked
higher than
78.11%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
RMD:
17.65
Ranked among companies with meaningful Net Margin only.
|
Net Margin range over the past 10 years
Min: 13.49, Med: 18.44, Max: 22.2
Current: 17.65
|
| ROE % | 22.27 |
ROE ranked
higher than
74.75%
of
198
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
RMD:
22.27
Ranked among companies with meaningful ROE only.
|
ROE range over the past 10 years
Min: 13.33, Med: 17.28, Max: 21.47
Current: 22.27
|
| ROA % | 12.64 |
ROA ranked
higher than
74.27%
of
206
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
RMD:
12.64
Ranked among companies with meaningful ROA only.
|
ROA range over the past 10 years
Min: 9.66, Med: 12.21, Max: 15.54
Current: 12.64
|
| ROC (Joel Greenblatt) % | 70.77 |
ROC (Joel Greenblatt) ranked
higher than
86.76%
of
204
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
RMD:
70.77
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
|
ROC (Joel Greenblatt) range over the past 10 years
Min: 31.17, Med: 54.48, Max: 67.86
Current: 70.77
|
| 3-Year Total Revenue Growth Rate | 11.70 |
3-Year Revenue Growth Rate ranked
higher than
72.35%
of
170
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
RMD:
11.4
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
|
3-Year Revenue Growth Rate range over the past 10 years
Min: 7.9, Med: 18.1, Max: 32.3
Current: 11.4
|
| 3-Year Total EBITDA Growth Rate | 9.20 |
3-Year EBITDA Growth Rate ranked
lower than
65.16%
of
155
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 426.6, Med: 10, Min: -759
RMD:
8.8
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
|
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 21.3, Max: 76.3
Current: 8.8
|
| 3-Year EPS w/o NRI Growth Rate | -3.90 |
3-Year EPS w/o NRI Growth Rate ranked
lower than
69.03%
of
155
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 253, Med: 12.9, Min: -782.7
RMD:
-3.9
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
|
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: -3.9, Med: 20.3, Max: 66.7
Current: -3.9
|
» RMD's 30-Y Financials
Financials (Next Earnings Date: 2019-08-02)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NYSE:RMD
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Medical Instruments & Equipment » Medical Instruments & Supplies   NAICS : 339112   SIC : 3841 |
| Compare | TSE:7733 NYSE:COO XSWX:SOON NYSE:TFX XSWX:STMN NAS:XRAY TSE:4543 NAS:HOLX NYSE:VAR NYSE:STE OCSE:COLO B XTER:AFX NYSE:WST OCSE:DEMANT NAS:MASI TSE:7747 NYSE:HRC NZSE:FPH NYSE:HAE NAS:NVCR |
| Traded in other countries | RME.Germany 0KW4.UK |
| Address | 9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123 |
| ResMed develops, manufactures, and distributes medical devices--such as airflow generators and masks--to treat breathing disorders. It also markets ventilation products, but sleep apnoea remains the company's primary focus. ResMed's reach is truly global, with distribution capabilities in more than 70 countries through wholly owned and independent firms. An increasing proportion of manufacturing capacity is in Singapore, with some still in Australia, where the company was founded. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 39.14 |
PE Ratio ranked
lower than
80.80%
of
125
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1012.86, Med: 31.7, Min: 0.65
RMD:
39.14
Ranked among companies with meaningful PE Ratio only.
|
PE Ratio range over the past 10 years
Min: 16.93, Med: 23.53, Max: 51.4
Current: 39.14
|
| Forward PE Ratio | 29.50 |
Forward P/E ranked
lower than
57.50%
of
40
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 80, Med: 26.32, Min: 12.3
RMD:
29.5
Ranked among companies with meaningful Forward P/E only.
| N/A |
| PE Ratio without NRI | 39.14 |
PE without NRI ranked
lower than
79.67%
of
123
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1012.86, Med: 9999, Min: 0.65
RMD:
39.14
Ranked among companies with meaningful PE without NRI only.
|
PE without NRI range over the past 10 years
Min: 16.93, Med: 23.53, Max: 51.4
Current: 39.14
|
| Price-to-Owner-Earnings | 54.32 |
Price-to-Owner-Earnings ranked
lower than
62.65%
of
83
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 631.1, Med: 30.92, Min: 1.32
RMD:
54.32
Ranked among companies with meaningful Price-to-Owner-Earnings only.
|
Price-to-Owner-Earnings range over the past 10 years
Min: 12.98, Med: 24.45, Max: 74.05
Current: 54.32
|
| PB Ratio | 8.61 |
PB Ratio ranked
lower than
81.35%
of
193
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
RMD:
8.61
Ranked among companies with meaningful PB Ratio only.
|
PB Ratio range over the past 10 years
Min: 2.29, Med: 4.05, Max: 8.65
Current: 8.61
|
| PS Ratio | 6.89 |
PS Ratio ranked
lower than
72.40%
of
192
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
RMD:
6.89
Ranked among companies with meaningful PS Ratio only.
|
PS Ratio range over the past 10 years
Min: 2.77, Med: 4.55, Max: 6.92
Current: 6.89
|
| Price-to-Free-Cash-Flow | 46.52 |
Price-to-Free-Cash-Flow ranked
lower than
63.51%
of
74
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
RMD:
46.52
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
|
Price-to-Free-Cash-Flow range over the past 10 years
Min: 13.35, Med: 25.07, Max: 59.39
Current: 46.52
|
| Price-to-Operating-Cash-Flow | 38.93 |
Price-to-Operating-Cash-Flow ranked
lower than
71.28%
of
94
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
RMD:
38.93
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
|
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 10.7, Med: 18.65, Max: 38.93
Current: 38.93
|
| EV-to-EBIT | 31.15 |
EV-to-EBIT ranked
lower than
62.81%
of
121
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
RMD:
31.15
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: 10.8, Med: 17.1, Max: 31.3
Current: 31.15
|
| EV-to-EBITDA | 25.20 |
EV-to-EBITDA ranked
lower than
59.42%
of
138
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
RMD:
25.2
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: 8.5, Med: 13.9, Max: 25.5
Current: 25.2
|
| EV-to-Revenue | 7.32 |
EV-to-Revenue ranked
lower than
72.86%
of
199
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
RMD:
7.32
Ranked among companies with meaningful EV-to-Revenue only.
|
EV-to-Revenue range over the past 10 years
Min: 2.5, Med: 4.25, Max: 7.4
Current: 7.32
|
| PEG Ratio | 6.02 |
PEG Ratio ranked
lower than
84.06%
of
69
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 112.54, Med: 2.7, Min: 0.05
RMD:
6.02
Ranked among companies with meaningful PEG Ratio only.
|
PEG Ratio range over the past 10 years
Min: 0.69, Med: 1.76, Max: 10.02
Current: 6.02
|
| Shiller PE Ratio | 53.07 |
Shiller PE Ratio ranked
higher than
50.00%
of
54
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 600, Med: 50.97, Min: 0.42
RMD:
53.07
Ranked among companies with meaningful Shiller PE Ratio only.
|
Shiller PE Ratio range over the past 10 years
Min: 30.9, Med: 42.38, Max: 61.11
Current: 53.07
|
| Current Ratio | 2.38 |
Current Ratio ranked
lower than
81.00%
of
200
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
RMD:
2.38
Ranked among companies with meaningful Current Ratio only.
|
Current Ratio range over the past 10 years
Min: 0.87, Med: 4.02, Max: 6.44
Current: 2.38
|
| Quick Ratio | 1.69 |
Quick Ratio ranked
lower than
74.63%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
RMD:
1.69
Ranked among companies with meaningful Quick Ratio only.
|
Quick Ratio range over the past 10 years
Min: 0.61, Med: 3.14, Max: 5.71
Current: 1.69
|
| Days Inventory | 101.83 |
Days Inventory ranked
higher than
60.91%
of
197
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
RMD:
101.83
Ranked among companies with meaningful Days Inventory only.
|
Days Inventory range over the past 10 years
Min: 100.21, Med: 112.06, Max: 157.01
Current: 101.83
|
| Days Sales Outstanding | 73.92 |
Days Sales Outstanding ranked
lower than
73.33%
of
165
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 655.77, Med: 61.97, Min: 1
RMD:
73.92
Ranked among companies with meaningful Days Sales Outstanding only.
|
Days Sales Outstanding range over the past 10 years
Min: 75.44, Med: 77.78, Max: 84.41
Current: 73.92
|
| Days Payable | 43.51 |
Days Payable ranked
lower than
74.17%
of
151
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 713.41, Med: 54.66, Min: 2
RMD:
43.51
Ranked among companies with meaningful Days Payable only.
|
Days Payable range over the past 10 years
Min: 34.6, Med: 41.96, Max: 55.15
Current: 43.51
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| Dividend Yield % | 1.23 |
Trailing Dividend Yield ranked
higher than
62.20%
of
164
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 106.45, Med: 1.16, Min: 0.01
RMD:
1.23
Ranked among companies with meaningful Trailing Dividend Yield only.
|
Trailing Dividend Yield range over the past 10 years
Min: 0.41, Med: 1.71, Max: 2.26
Current: 1.23
|
| Dividend Payout Ratio | 0.47 |
Dividend Payout Ratio ranked
lower than
53.00%
of
100
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 10, Med: 0.31, Min: 0.01
RMD:
0.47
Ranked among companies with meaningful Dividend Payout Ratio only.
|
Dividend Payout Ratio range over the past 10 years
Min: 0.32, Med: 0.47, Max: 0.64
Current: 0.47
|
| 3-Year Dividend Growth Rate (Per Share) | 7.70 |
3-Year Dividend Growth Rate ranked
higher than
54.84%
of
62
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 72.6, Med: 8.9, Min: -100
RMD:
7.7
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
|
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 20.8
Current: 7.7
|
| Forward Dividend Yield % | 1.24 |
Forward Dividend Yield ranked
higher than
60.25%
of
161
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 10.53, Med: 1.3, Min: 0.02
RMD:
1.24
Ranked among companies with meaningful Forward Dividend Yield only.
| N/A |
| Yield-on-Cost (5-Year) % | 2.35 |
Yield-on-Cost (5y) ranked
lower than
51.67%
of
209
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 106.45, Med: 1.44, Min: 0.01
RMD:
2.35
Ranked among companies with meaningful Yield-on-Cost (5y) only.
|
Yield-on-Cost (5y) range over the past 10 years
Min: 0.78, Med: 3.26, Max: 4.31
Current: 2.35
|
| 3-Year Share Buyback Rate | -0.50 |
3-Year Share Buyback Rate ranked
higher than
74.83%
of
143
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 9.1, Med: -5, Min: -273.3
RMD:
-0.5
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
|
3-Year Share Buyback Rate range over the past 10 years
Min: -44.2, Med: -2, Max: 2.6
Current: -0.5
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Projected-FCF | 2.67 |
Price-to-Intrinsic-Value-Projected-FCF ranked
higher than
52.00%
of
75
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 161.65, Med: 2.41, Min: 0.16
RMD:
2.67
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
|
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.34, Med: 2.67, Max: 22.95
Current: 2.67
|
| Price-to-DCF (Earnings Based) | 2.25 |
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked
higher than
65.22%
of
23
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 94.53, Med: 2.2, Min: 1.04
RMD:
2.25
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
|
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.69, Med: 0.92, Max: 2.86
Current: 2.25
|
| Price-to-Median-PS-Value | 1.52 |
Price-to-Median-PS-Value ranked
lower than
70.00%
of
160
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
RMD:
1.52
Ranked among companies with meaningful Price-to-Median-PS-Value only.
|
Price-to-Median-PS-Value range over the past 10 years
Min: 0.43, Med: 1.04, Max: 2.4
Current: 1.52
|
| Price-to-Peter-Lynch-Fair-Value | 5.16 |
Price-to-Peter-Lynch-Fair-Value ranked
lower than
91.11%
of
45
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 111.95, Med: 2.46, Min: 0.26
RMD:
5.16
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
|
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.71, Med: 1.58, Max: 8.45
Current: 5.16
|
| Earnings Yield (Joel Greenblatt) % | 3.21 |
Earnings Yield (Greenblatt) ranked
higher than
63.29%
of
207
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
RMD:
3.21
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.2, Med: 5.85, Max: 9.3
Current: 3.21
|
| Forward Rate of Return (Yacktman) % | 9.81 |
Forward Rate of Return ranked
lower than
53.47%
of
101
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 28.23, Med: 8.66, Min: -123.3
RMD:
9.81
Ranked among companies with meaningful Forward Rate of Return only.
|
Forward Rate of Return range over the past 10 years
Min: 7.6, Med: 15.6, Max: 23.5
Current: 9.81
|
More Statistics
| Revenue (TTM) (Mil) $ | 2,525.24 |
| EPS (TTM) $ | 3.08 |
| Beta | 0.33 |
| Volatility % | 24.8 |
| 52-Week Range $ | 90.64 - 121 |
| Shares Outstanding (Mil) | 143.28 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 6 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | N |
| Higher Current Ratio yoy | N |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | Y |
| Higher Asset Turnover yoy | Y |